Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2000
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162434 Cytomodulating peptide for inhibiting lymphocyte activity
12/19/2000US6162432 Increased t cell activation and abnormal antigen in the dermis and epidermis
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000US6162426 Increasing neutrophil production in very low birth weight infants by administering granulocyte colony stimulating factor (g-csf)
12/19/2000CA2189527C Novel elastase inhibitors
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/19/2000CA2096520C Therapeutic agent for skin or corneal disease
12/19/2000CA2067244C Monoclonal antibody specific for iga receptor
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075658A2 Detection of ryanodine receptor antibodies
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075358A2 Mammalian toll homologues and uses thereof
12/14/2000WO2000075352A2 Hcv/bvdv chimeric genomes and uses thereof
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075345A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075338A2 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
12/14/2000WO2000075336A2 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075329A1 Targeted angiogenesis
12/14/2000WO2000075327A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075326A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000WO2000075325A1 Lifeguard (lfg) polynucleotides and polypeptides and methods of use thereof
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075321A2 Polynucleotides and membrane-bound polypeptide encoded thereby
12/14/2000WO2000075320A2 Human genes and proteins encoded thereby
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075316A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075314A1 Novel hemopoietin receptor protein nr10
12/14/2000WO2000075312A1 Cd44 splice variant associated with rheumatoid arthritis
12/14/2000WO2000075310A1 Interleukin-1-receptor associated kinase-3 (irak3)
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000WO2000075291A2 Cells with enforced expression of bcl-xl
12/14/2000WO2000075281A2 Supercritical fluid-assisted nebulization and bubble drying
12/14/2000WO2000075280A2 A member of the frzb family, frazzled
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075184A1 Modulation of protein levels using the scf complex
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000075181A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075178A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000WO2000075177A1 Echinocandin derivatives, method for preparing same and application as antifungal agents
12/14/2000WO2000075176A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075174A1 Heart homing peptides and methods of using same
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000WO2000075168A1 Mouse urotensin-ii receptor (utb-r)
12/14/2000WO2000075164A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075162A1 A compound containing a labile disulfide bond
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074736A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
12/14/2000WO2000074726A1 METHODS AND COMPOSITIONS FOR PREVENTING p53 MEDIATED APOPTOSIS
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074723A2 Methods for the gene therapy of benign prostatic hyperplasia and medical agents therefore
12/14/2000WO2000074721A1 Vitamin directed dual targeting therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074713A1 Autologous thrombin
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074711A2 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
12/14/2000WO2000074710A2 Methods for treating diabetes
12/14/2000WO2000074709A2 Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres
12/14/2000WO2000074708A1 Method for treating endotoxic shock and inflammatory and autoimmune diseases in mammals
12/14/2000WO2000074707A2 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074704A1 Transcription factors related to tfiia
12/14/2000WO2000074703A2 Therapeutic agent comprising a botulinum neurotoxin
12/14/2000WO2000074702A1 Compositions for the treatment of the catabolic state of prolonged critical illness
12/14/2000WO2000074701A2 Method and composition for inhibiting cardiovascular cell proliferation
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074676A1 Use of riluzole for the treatment of multiple sclerosis
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074650A2 Implantable gel compositions and method of manufacture
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000074497A1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
12/14/2000WO2000074485A1 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors
12/14/2000WO2000057190A3 Prediction of diabetes impaired wound healing
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053148A3 Methods and compositions for treating erectile dysfunction
12/14/2000WO2000051623A3 Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
12/14/2000WO2000050588A3 Genes associated with diseases of the colon
12/14/2000WO2000050070A3 Preparation for the treatment of pigmentation disorders
12/14/2000WO2000049135A3 Substrate for cell growth
12/14/2000WO2000049040A3 Antimicrobial/endotoxin neutralizing polypeptide
1 ... 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 ... 3163